Johns Hopkins Institute for NanoBioTechnology: Discovery of Mutation-Induced Signaling Bias on the Cell Surface Unveils New Cancer Treatment Avenues
January 09, 2024
January 09, 2024
BALTIMORE, Maryland, Jan. 9 (TNSres) -- Johns Hopkins Institute for NanoBioTechnology issued the following news:
External factors known as "ligands" bind to cell surface receptors called "growth factor receptors" and when they do, it sparks a series of reactions that drive cell growth, tissue development, and wound healing. A phenomenon, known as "signaling bias," describes the ability of these receptors to preferentially trigger some reactions over oth . . .
External factors known as "ligands" bind to cell surface receptors called "growth factor receptors" and when they do, it sparks a series of reactions that drive cell growth, tissue development, and wound healing. A phenomenon, known as "signaling bias," describes the ability of these receptors to preferentially trigger some reactions over oth . . .